News

Vetanco & Bioinnovo at the CRWAD Conference

Our specialists participated in the “Conference of Research Workers in Animal Diseases 2020” held virtually last December 5-8. The “Conference of Research Workers in Animal Diseases 2020”, locally known as “CRWAD 2020 Conference” took place last December 5-8 in a virtual modality.   Bioinnovo–Vetanco and Vetanco USA specialists…

New achievements in the fight against COVID-19

Bioinnovo SA was part of a multidisciplinary team responsible for the development of avian IgY antibodies that neutralize the virus causing COVID-19 The project, “Development and production of critical reagents for COVID-19 diagnosis and treatment: Nanobodies, IgY polyclonal antibodies and recombinant proteins,” was undertaken by…

100% Argentinian technology for the COVID-19 test

Specialists of the National Institute of Industrial Technology (INTI) and the national company Ivema Desarrollos designed an essential device for a rapid diagnostic test to substitute imports, reduce costs to the half and meet the local demand that is currently with a shortage of stock. This device…

Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis

Bioinnovo, the public-private company (INTA–Vetanco) made its first contribution to the macro collaborative project conducted by a scientific committee that brings together more than twenty male and female researchers from different institutions. Those institutions are the Institute of Science and Technology César Milstein (Conicet –…

Bioinnovo, Algenex reinforce vaccine molecule Arrangement

Argentina’s Bioinnovo has updated its partnership with Spanish firm Algenex for the use of a molecule developed by the latter The renewed partnership provides Bioinnovo with the international rights to use Algenex’s APCH (antigen presenting cells homing) molecule in the _eld of animal health. Bioinnovo…